# Progress Note 04 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Marcus Aurelius (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC004-SYN
- Date: 2026-07-07
- Fictional facility: St. Posthumous Health Center
- Fictional author: Octavia Ashworth-Nnamdi, MD
- Calendar frame: modern shifted

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Fever, sore throat and cough for two days; home COVID-19 test positive. **S**

## History of present illness

Mr. Aurelius called this morning after a positive home antigen test and was seen the same day at the end of clinic, masked and in a separate room. Two days ago he developed a sore throat, aches and a temperature of 38.5 °C, followed by a dry cough. Several people on his staff have been unwell this week. He is not short of breath, has no chest pain, and can walk about his quarters without difficulty. He is eating little but drinking well. He had his last COVID-19 vaccine about ten months ago. His reflux has been quiet on omeprazole. He has taken his herbal paste as usual on alternate nights, no more, and asks whether he may take a cough syrup at night to sleep. The repeat antigen test here is positive. **S**

| Element | Detail |
|---|---|
| Onset | Two days ago, after contacts at work were unwell |
| Symptoms | Fever to 38.5 °C, sore throat, dry cough, aches; no breathlessness or chest pain |
| Test | Rapid SARS-CoV-2 antigen test positive at home and in clinic |
| Context | Age 53; vaccinated about ten months ago; no lung, heart, kidney or immune condition; opium-containing remedy on alternate nights; omeprazole |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fever, aches and tiredness; eating less; drinking well |
| Ears, nose, mouth, and throat | Positive | Sore throat and a blocked nose |
| Respiratory | Positive | Dry cough; no breathlessness or wheeze |
| Cardiovascular | Negative | No chest pain or palpitations |
| Gastrointestinal | Negative | No heartburn, vomiting or diarrhea; stools soft on the laxative |
| Neurological | Negative | No confusion; mild headache |

6 systems reviewed. **S**

## Current medications

- Polyethylene glycol 3350 powder, 17 g dissolved in a glass of water by mouth once daily as needed for constipation **S**
- Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose, repeated in 2 to 3 minutes in the other nostril if there is no response; call 911 **S**
- Omeprazole 20 mg delayed-release capsule, one capsule by mouth 30 to 60 minutes before breakfast for eight weeks, for erosive esophagitis **S**
- Opium-containing compounded herbal paste (unregulated, strength unknown), about 0.5 g by mouth at bedtime on alternate nights, a reduction he chose and made himself **S**
- Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for fever or aches, no more than 3 g a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/74 mmHg; pulse 94 bpm; respirations 16/min; temperature 38.3 °C; oxygen saturation 97% on room air; weight 63.6 kg; BMI 21.5 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Tired but comfortable; speaks in full sentences; temperature 38.3 °C, pulse 94, respiratory rate 16, blood pressure 118/74, oxygen saturation 97% on room air |
| Throat | Pharynx red without exudate; no swollen tonsils |
| Neck | Small tender anterior cervical nodes |
| Respiratory | Normal effort; clear breath sounds; no crackles or wheeze |
| Cardiovascular | Regular rhythm; no murmur |
| Neurological | Alert; not drowsy; pupils normal size |

All examination findings are synthetic. **S**

## Assessment and plan

1. **COVID-19, mild** (U07.1). Mild illness on day two: no breathlessness, a normal oxygen saturation and clear lungs. Age over 50 raises the risk of severe disease, and the risk rises steeply after 65; he has no other risk condition and is vaccinated. Nirmatrelvir with ritonavir was offered: ritonavir changes how many drugs are handled, and with an opium paste of unknown strength the effect on him cannot be predicted closely; omeprazole is not a problem. After discussion he declined, preferring to watch and return if worse. Remdesivir infusions were not wanted. **S**
   - Rest, fluids and acetaminophen as needed, no more than 3 g a day.
   - Honey in warm water for the cough; no codeine or dextromethorphan cough syrup, sedating antihistamine or sleep aid while he takes the remedy.
   - Stay away from others until fever-free for 24 hours without medicine and improving, then mask and keep distance for five more days; work from his quarters.
   - Call 911 for breathlessness, chest pain, confusion or blue lips; return for oxygen saturation below 94% on the home oximeter.
   - Review at the preventive visit in three weeks.
2. **Opium-containing remedy during an acute illness** (F11.90). Illness, poor sleep and cough can tempt a larger dose, and fever can make an opioid's sedation harder to judge. He is alert, his pupils and breathing are normal, and he has taken no more than usual. **S**
   - No more than his usual amount, and none on a night he feels drowsy.
   - Naloxone at his bedside; a colleague in his quarters knows where it is and how to use it.
   - No alcohol while unwell.
3. **Reflux esophagitis on omeprazole** (K21.00). Quiet; coughing can bring on heartburn. **S**
   - Continue omeprazole each morning to complete eight weeks.

## Medication changes

- Started: Acetaminophen 500 mg oral tablet, one or two tablets by mouth every six hours as needed for fever or aches, no more than 3 g a day **S**

## Guideline basis

- CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recomm Rep 2022;71(3):1-95)
- Preventing Spread of Respiratory Viruses When You're Sick (2024), Centers for Disease Control and Prevention
- COVID-19 Treatment: Clinical Care for Outpatients (2025), Centers for Disease Control and Prevention
- IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (living guideline), Infectious Diseases Society of America

## Follow-up

- Preventive visit in three weeks as booked; return sooner for breathlessness, chest pain, a low oxygen reading, or fever beyond five days. **S**
- Next scheduled visit 2026-07-28: periodic adult preventive visit. **S**
